Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 748

1.

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.

Marx N, Duez H, Fruchart JC, Staels B.

Circ Res. 2004 May 14;94(9):1168-78. Review.

2.

Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.

Touyz RM, Schiffrin EL.

Vascul Pharmacol. 2006 Jul;45(1):19-28. Epub 2006 Jun 16. Review.

PMID:
16782410
3.

Peroxisome proliferator-activated receptors and the control of inflammation.

Cabrero A, Laguna JC, Vázquez M.

Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):243-8. Review.

PMID:
14561188
4.

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.

Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B, van Bilsen M.

Circ Res. 2003 Mar 21;92(5):518-24. Epub 2003 Feb 6.

5.

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.

Chinetti G, Fruchart JC, Staels B.

Z Kardiol. 2001;90 Suppl 3:125-32. Review.

PMID:
11374025
6.
7.
8.

Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.

Jia Y, Qi C, Kashireddi P, Surapureddi S, Zhu YJ, Rao MS, Le Roith D, Chambon P, Gonzalez FJ, Reddy JK.

J Biol Chem. 2004 Jun 4;279(23):24427-34. Epub 2004 Mar 29.

9.

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.

Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, Staels B.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):717-26. Review.

10.

Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.

Gouni-Berthold I, Krone W.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):513-23. Review.

PMID:
16503871
11.
12.

Peroxisome proliferator-activated receptors: from genes to physiology.

Kliewer SA, Xu HE, Lambert MH, Willson TM.

Recent Prog Horm Res. 2001;56:239-63. Review.

PMID:
11237216
13.

Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences.

Holden PR, Tugwood JD.

J Mol Endocrinol. 1999 Feb;22(1):1-8. Review.

PMID:
9924174
14.
15.
17.

PPARs: transcription factors controlling lipid and lipoprotein metabolism.

Bocher V, Pineda-Torra I, Fruchart JC, Staels B.

Ann N Y Acad Sci. 2002 Jun;967:7-18. Review.

PMID:
12079830
19.

Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.

Wagner KD, Wagner N.

Pharmacol Ther. 2010 Mar;125(3):423-35. doi: 10.1016/j.pharmthera.2009.12.001. Epub 2009 Dec 22. Review.

PMID:
20026355
20.

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A.

Nature. 1998 Jun 25;393(6687):790-3.

PMID:
9655393

Supplemental Content

Support Center